Julia E. Lefler

Julia E. Lefler

Auto-generated profile, based on publicly available information

Julia E. Lefler

Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
DRDenys Rujchanarong
Denys Rujchanarong
JLJulia Lefler
Julia Lefler
JSJanet E. Saunders
Janet E. Saunders
SPSarah Pippin
Sarah Pippin
LSLaura Simmons Spruill
Laura Simmons Spruill
PAPeggi Angel
Peggi Angel
Breast stroma plays a significant role in breast cancer risk and progression yet remains poorly understood. In breast stroma, collagen is the most abundantly expressed protein and its increased deposition and alignment contributes to progression and poor prognosis. Collagen post-translation modifications such as hydroxylated-proline (HYP) control deposition and stromal organization. The clinical relevance of collagen HYP site modifications in cancer processes remains undefined due to technical issues accessing collagen from formalin-fixed, paraffin-embedded (FFPE) tissues. We previously developed a targeted approach for investigating collagen and other extracellular matrix proteins from FFPE tissue. Here, we hypothesized that immunohistochemistry staining for fibroblastic markers would not interfere with targeted detection of collagen stroma peptides and could reveal peptide regulation influenced by specific cell types. Our initial work demonstrated that stromal peptide peak intensities when using MALD-IMS following IHC staining (αSMA, FAP, P4HA3 and PTEN) were comparable to serial sections of nonstained tissue. Analysis of histology-directed IMS using PTEN on breast tissues and TMAs revealed heterogeneous PTEN staining patterns and suggestive roles in stromal protein regulation. This study sets the foundation for investigations of target cell types and their unique contribution to collagen regulation within extracellular matrix niches.

20 February 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SGSankha Ghosh
Sankha Ghosh
CMCatherine B. MarElia-Bennett
Catherine B. MarElia-Bennett
BHBlake Hildreth
Blake Hildreth
JLJulia E. Lefler
Julia E. Lefler
SSSudarshana M. Sharma
Sudarshana M. Sharma
MOMichael C. Ostrowski
Michael C. Ostrowski
Angiogenesis is a highly orchestrated process involving complex crosstalk between several endothelial cell processes including cell cycle, cell survival and migration. Transcription factors ETS1 and ETS2 are required for EC functions necessary for embryonic angiogenesis. Here, by utilizing endothelial cell-specific deletion of Ets1 and Ets2 on post-natal angiogenesis we demonstrate that ETS1 and ETS2 have a redundant regulatory role in controlling the expression of key G2/M regulators and anti-apoptotic gene modules by recruiting the transcriptional activator CBP/p300 to the enhancers of these genes. Further, cultured aortic ECs lacking both ETS1 and ETS2 demonstrated G 2 /M phase arrest and increased apoptosis. In vivo , EC infiltration and invasion was attenuated when matrigel admixed with mouse mammary tumor cells was injected into adult mice with EC-specific ablation of Ets1 and Ets2 . These results demonstrate that deletion of Ets1 and Ets2 in endothelial cells inhibits angiogenesis by altering cell cycle progression and decreasing cell survival.